{"id":18360,"date":"2021-04-02T08:36:15","date_gmt":"2021-04-02T12:36:15","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=18360"},"modified":"2021-04-02T08:36:15","modified_gmt":"2021-04-02T12:36:15","slug":"pipeline-reloads-nine-deals-file-including-another-endeavor-attempt","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-reloads-nine-deals-file-including-another-endeavor-attempt\/","title":{"rendered":"Pipeline Reloads: Nine deals file including another Endeavor attempt"},"content":{"rendered":"

NEW FILINGS<\/strong><\/span><\/p>\n

Company: Aveanna Healthcare Holdings Inc.
\nSymbol: AVAH
\nDescription: They are a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations..
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Barclays, JP Morgan, BMO Capital, Credit Suisse, BofA Securities, Deutsche Bank, Jefferies, RBC Capital, Truist Securities
\nCo-Manager(s): Raymond James, Stephens Inc
\nFiled: 4-1-21
\nListed Cash Raise: $100m<\/p>\n

Company: UiPath Inc
\nSymbol: PATH
\nDescription: They provide their customers with a robust set of capabilities to discover automation opportunities and build, manage, run, engage, measure, and govern automations across departments within an organization.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, JP Morgan, BofA Securities, Credit Suisse, Barclays, Wells Fargo
\nCo-Manager(s): SMBC Nikko, BMO Capital, Mizuho Securities, KeyBanc Capital, TD Securities, Truist Securities, Cowen, Evercore ISI, Macquarie Capital, Nomura, RBC Capital, Canaccord Genuity, DA Davidson, Oppenheimer, Needham
\nFiled: 3-25-21
\nListed Cash Raise: $1 billion<\/p>\n

Company: Latham Group, Inc.
\nSymbol: SWIM
\nDescription: They are the largest designer, manufacturer and marketer of in-ground residential swimming pools in North America, Australia and New Zealand.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Barclays, BofA Securities, Morgan Stanley, Goldman Sachs
\nCo-Manager(s): Nomura, William Blair, Baird, KeyBanc Capital, Truist Securities
\nFiled: 3-31-21
\nListed Cash Raise: $100m<\/p>\n

Company: IN8bio, Inc.
\nSymbol: INAB
\nDescription: They are a clinical-stage biotechnology company focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Cowen, Stifel, Mizuho Securities
\nFiled: 3-31-21
\nListed Cash Raise: $69m
\nNote: Previously Postponed in November 2020<\/p>\n

Company: Endeavor Group Holdings, Inc.
\nSymbol: EDR
\nDescription: Endeavor is a premium intellectual property, content, events, and experiences company.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, JP Morgan, KKR, Deutsche Bank, Barclays, Citigroup, Credit Suisse, Evercore ISI, HSBC, Jefferies, Moelis & Co., Piper Sandler, RBC Capital Markets, UBS Investment Bank
\nCo-Manager(s): CODE Advisors, DBO Partners, LionTree, Academy Securities, R Seelaus & Co., Ramirez & Co., Siebert Cisneros Shank
\nFiled: 3-31-21
\nListed Cash Raise: $100m<\/p>\n

Company: Treace Medical Concepts, Inc.
\nSymbol: TMCI
\nDescription: They are a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions).
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Morgan Stanley
\nCo-Manager(s): SVB Leerink, Stifel
\nFiled: 3-30-21
\nListed Cash Raise: $100m<\/p>\n

Company: FTC Solar, Inc.
\nSymbol: FTCI
\nDescription: They Are a global provider of advanced solar tracker systems, supported by proprietary software and value-added engineering services.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Barclays, BofA Securities, UBS Investment Bank
\nCo-Manager(s): HSBC
\nFiled: 3-26-21
\nListed Cash Raise: $100m<\/p>\n

Company: Biomea Fusion, Inc.
\nSymbol: BMEA
\nDescription: They are a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Jefferies, Piper Sandler
\nFiled: 3-26-21
\nListed Cash Raise: $100m<\/p>\n

Company: Akoya Biosciences, Inc.
\nSymbol: AKYA
\nDescription: They are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Morgan Stanley, Piper Sandler, Canaccord Genuity
\nFiled: 3-26-21
\nListed Cash Raise: $115m<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-18360","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=18360"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18360\/revisions"}],"predecessor-version":[{"id":18361,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/18360\/revisions\/18361"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=18360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=18360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=18360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}